Ron Yamamoto, Chief Scientific Officer and Director, is an experienced medical technologist and executive. His management experience includes CEO, CSO, VP of R&D and board member positions at Vitaphore Corporation, Point Biomedical Corporation and Biocept, Inc. Mr. Yamamoto has been involved in the development of numerous medical products and corporate partnerships in the medical device and pharmaceutical industries. He has a strong background in biomaterial science, biochemistry, and intellectual property strategy. Mr. Yamamoto holds over two dozen patents related to medical technologies and products. Mr. Yamamoto received a BS degree from the California Institute of Technology in the study of chemical engineering and chemistry and an MS degree from Clemson University in the study of biomaterial engineering and biochemistry, with postgraduate studies at the University of Southern California in the study of biochemistry.
Stan Conston is a co-founder of iScience Interventional. He currently serves as Vice President of Research & Development. At iScience, Stan is responsible for product research and design as well as testing and clinical development of new products and concepts. Stan has over 25 years of life science experience and has been a founder or founding team member of four medical device startups in the Silicon Valley. Stan has extensive experience in the design, development, and testing of a wide variety of medical products, having worked in areas ranging from urology to neurology. He holds over 60 patents and published patent applications in the field and received a degree in physics from the University of California, Santa Barbara.